Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

AI helps diagnose dogs suffering chronic pain
Pain associated with CM is challenging to confirm
Facial changes associated with Chiari-like malformation identified

Cavalier King Charles spaniel (CKCS) dogs are predisposed to Chiari-like malformation (CM) – a disease that causes deformity of the skull, neck (cranial cervical vertebrae) and, in some extreme cases, leads to spinal cord damage called syringomyelia (SM). While SM is straightforward to diagnose, pain associated with CM is challenging to confirm.

A new artificial intelligence (AI) technique, developed by the University of Surrey, could eventually help veterinary professionals to identify individual dogs with CM. The same technique identified unique biomarkers that have inspired further research into the facial changes in dogs affected by Chiari-like malformation (CM).

In a paper published in the Journal of Veterinary Internal Medicine, researchers from Surrey’s Centre for Vision, Speech and Signal Processing (CVSSP) and the School of Veterinary Medicine (SVM) detail how they used a completely automated, image-mapping method to discover patterns in MRI data that could help vets identify dogs that suffer from CM-associated pain.

The research helped identify features that characterise the differences in the MRI images of dogs with clinical signs of pain associated with CM and those with syringomyelia, from healthy dogs. The AI identified the floor of the third ventricle and its close neural tissue, and the region in the sphenoid bone as biomarkers for pain associated with CM; and the presphenoid bone and the region between the soft palate and the tongue for SM.
 
Identification of these biomarkers inspired further research, that found that dogs with pain associated with CM had more brachycephalic features with reduction of nasal tissue and a well-defined stop.
 
Dr Penny Knowler, the SVM’s lead author of the work, said: “This study suggests that the whole skull, rather than just the hindbrain, should be analysed in diagnostic tests. It also impacts on how we should interpret MRI from affected dogs and the choices we make when we breed predisposed dogs and develop breeding recommendations."
 
Adrian Hilton, distinguished professor from the University of Surrey and director of CVSSP, said: “This project demonstrates the potential for AI using machine learning to provide new diagnostic tools for animal health. Collaboration between experts in CVSSP and Surrey’s School of Veterinary Medicine is pioneering new approaches to improve animal health and welfare.”
 
Both studies were funded by the Memory of Hannah Hasty Research Fund. The AI study was also supported by the Pet Plan Charitable Trust.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.